In previous articles I have highlighted a few companies I think are strong M&A targets for future proofing pipelines of larger pharma companies looking to move into or maintain a position in the obesity and T2D field
Congress appropriated the funding following Hurricanes Idalia in 2023 and Helene in 2024, and HUD awarded St
Get the Plan + Blueprint Designed by Dan Chase, RD a registered dietitian who's worked with 1,000+ GLP-1 patients on Ozempic, Wegovy, Mounjaro, and Zepbound
For instance, a woman who reported a 5-year history of painful lichenoid lesions on the left mucosa and on the left side of the tongue adjacent to a dental metal prosthesis containing copper, had all these symptoms relieved after the prosthesis was substituted to one without copper
Andreeff M , Darzynkiewicz Z, Clarkson BD, Miller D, Melamed MR